Date: Thursday, August 18, 2022
Time: 2pm ET / 11am PT
Duration: 1 Hour
Fierce Biotech Webinar - Harnessing the Potential of Next-Generation Disease Models with CRISPR
Attend our webinar, where we will look at recent developments using CRISPR in disease modeling.
- CRISPR-Cas9 is a unique technology that enables geneticists and medical researchers to edit parts of the genome by removing, adding, or altering sections of the DNA sequence. It is currently the simplest, most versatile, and precise method of genetic manipulation and has led to extensive options for researchers to study the pathogenesis of disease. CRISPR-Cas9 is simpler, cheaper, and more precise than previous gene editing techniques and has a vast range of real-world applications, from curing genetic disease, improving livestock vitality to creating drought-resistant crops.
- In addition to becoming the go-to gene-editing tool, CRISPR has been used to generate alternative in vivo and in vitro models for a range of different diseases. CRISPR-Cas9 gene editing allows researchers to make precise, targeted changes to genomic sequences relatively easily and at comparatively low cost providing a powerful tool for the creation of precise disease models.
- CRISPR Cas9 can be used to alter specific genes, either by knockout, replacement, or regulation of gene expression to specifically mirror the genetic changes that feature in disease states giving researchers rich insights into the biology driving disease and identify potential therapeutic targets.
Eric Rhodes, CEO, ERS Genomics
Lukas Dow PhD, Associate Professor of Biochemistry in Medicine Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine
Dr Christopher Kirton, PhD, Chief Executive Officer, DefiniGEN
Robert Deans, Chief Scientific Officer, Synthego Corporation